Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 1/1/2026
  • 1/1/2026China's Supreme Court Upholds Semaglutide Patent, Strengthening IP Pro...
  • 1/1/2026
  • 1/1/2026CDE Issues Technical Guidelines for Clinical Trials of Eosinophilic Es...
  • 1/1/2026CDE Issues Technical Guidelines for Clinical Trials of Drugs Treating ...
  • 1/1/2026CDE Releases Technical Guidelines for Targeted Biologics in Chronic Ai...
  • 1/1/2026CDE Issues Technical Guidelines for Pan-Cancer Drug Clinical Developme...
  • 1/1/2026NMPA Publishes 100th Batch of Reference Formulations for Generic Drugs
  • 1/1/2026China's NMPA Issues Updated Bevacizumab Labeling Requirements
  • 1/1/2026Transcenta and EirGenix Partner to Expand Global Access to Affordable ...
  • 1/1/2026Youcare Files for Hong Kong IPO to Expand Innovative Drug Pipeline
  • 1/1/2026Zelgen and AbbVie Strike Global Licensing Deal for Trispecific TCE ZG0...
  • 1/1/2026Akeso's Pempulimab Wins New Approval in China
  • 1/1/2026J&J's Subcutaneous Amivantamab Regimen for EGFR-Mutant Lung Cancer App...
  • 1/1/2026Kousai Secures Strategic Financing to Advance Dendritic Cell Vaccine P...
  • 1/1/2026Moucellion Raises Pre-A Financing to Advance iPSC Therapies for Eye Di...
  • 1/1/2026InSilico Debuts on HKEX in Hong Kong's Largest Biotech IPO of the Year
  • 12/30/2025Suzhou Launches China's First Nuclear Medicine Demonstration Base
  • 12/30/2025Ultra-Low Flu Shot Prices Highlight Intensifying Pressure on China’s ...
  • 12/30/2025HUTCHMED's Fanregratinib NDA Granted Priority Review in China
  • 12/30/2025Recbio's Files NDA for Shingles Vaccine REC610 China
  • 12/30/2025Novo Nordisk Cuts Price of Wegovy in China Ahead of Patent Expiry
  • 12/30/2025China Rejects Tianmai Biotech's Oral Insulin Capsule ORMD-0801
  • 12/30/2025Adlai Nortye Grants ASK Pharma Exclusive Rights for Pan-RAS Inhibitor ...
  • 12/30/2025AstraZeneca and Daiichi Sankyo Secures Chinese Approval of Enhertu fo...
  • 12/30/2025Innovent's Ipilimumab IBI310 for Neoadjuvant Therapy approved in China
  • 12/30/2025China Approves AstraZeneca and Ionis' Wainua for ATTRv-PN
  • 12/30/2025AstraZeneca's Fasenra Approved for EGPA in China
  • 12/30/2025Simcere Registers Phase 1 MRCT for EGFR/c-Met Bispecific ADC SIM0610 i...
  • 12/30/2025Innovent Submits Clinical Trial Application for Novel Bispecific Dual-...
  • Page:1/59 Total number of articles:1752: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group